Bloomage Biotechnology controversies

Efficacy marketing of Bloomage Biotech's hyaluronic acid drinking water questioned, drawing consumer council attention

In 2021, after Bloomage Biotech launched hyaluronic acid drinking water, its marketing of effects such as beauty and hydration was questioned by media and professionals. In 2023, the Shanghai Consumer Council further focused on evidence and advertising issues around oral hyaluronic acid, naming products such as Shuijiquan. The cited reports did not prove that ordinary foods can achieve medical aesthetics effects, nor did they provide a final illegal ruling against the product.

Shanghai Stock Exchange questions Huaxi Bio acquisition

Investigation

The Shanghai Stock Exchange sent Huaxi Bio an inquiry on September 29 about questions concerning its acquisition transaction, including the substantial difference between the target's valuations and reported financial figures. The article reports questions from the exchange, not a finding of wrongdoing.